Voss Capital LP Sells 422,210 Shares of Avantor, Inc. $AVTR

Voss Capital LP lowered its position in shares of Avantor, Inc. (NYSE:AVTR) by 9.3% in the 4th quarter, Holdings Channel.com reports. The fund owned 4,102,790 shares of the company’s stock after selling 422,210 shares during the quarter. Avantor comprises approximately 2.3% of Voss Capital LP’s investment portfolio, making the stock its 16th largest position. Voss Capital LP’s holdings in Avantor were worth $47,018,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in AVTR. EverSource Wealth Advisors LLC increased its position in shares of Avantor by 119.1% during the second quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock valued at $29,000 after acquiring an additional 1,189 shares in the last quarter. Strategic Wealth Investment Group LLC bought a new stake in shares of Avantor during the second quarter valued at approximately $32,000. Private Trust Co. NA increased its position in shares of Avantor by 46.2% during the fourth quarter. Private Trust Co. NA now owns 2,769 shares of the company’s stock valued at $32,000 after acquiring an additional 875 shares in the last quarter. Los Angeles Capital Management LLC bought a new stake in shares of Avantor during the fourth quarter valued at approximately $32,000. Finally, Osaic Holdings Inc. increased its position in shares of Avantor by 60.9% during the second quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock valued at $38,000 after acquiring an additional 1,064 shares in the last quarter. Institutional investors own 95.08% of the company’s stock.

Insiders Place Their Bets

In other Avantor news, Director Gregory T. Lucier acquired 10,000 shares of the business’s stock in a transaction dated Friday, May 8th. The stock was purchased at an average price of $8.32 per share, with a total value of $83,200.00. Following the transaction, the director directly owned 60,000 shares in the company, valued at approximately $499,200. The trade was a 20.00% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Simon Dingemans acquired 25,000 shares of the business’s stock in a transaction dated Friday, May 1st. The shares were acquired at an average cost of $8.14 per share, with a total value of $203,500.00. Following the transaction, the director owned 25,000 shares in the company, valued at approximately $203,500. This trade represents a ∞ increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders own 0.28% of the company’s stock.

Avantor Trading Down 3.0%

NYSE:AVTR opened at $9.38 on Friday. The company has a current ratio of 1.76, a quick ratio of 1.17 and a debt-to-equity ratio of 0.68. Avantor, Inc. has a 12 month low of $7.26 and a 12 month high of $15.93. The company has a market cap of $6.40 billion, a PE ratio of -11.57, a price-to-earnings-growth ratio of 5.60 and a beta of 0.97. The company has a 50 day simple moving average of $8.38 and a two-hundred day simple moving average of $9.63.

Avantor (NYSE:AVTR) last issued its quarterly earnings data on Wednesday, April 29th. The company reported $0.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.16 by $0.01. Avantor had a negative net margin of 8.42% and a positive return on equity of 9.95%. The firm had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.54 billion. During the same quarter in the previous year, the firm posted $0.23 EPS. The company’s revenue for the quarter was up .0% compared to the same quarter last year. Research analysts forecast that Avantor, Inc. will post 0.79 earnings per share for the current year.

Analysts Set New Price Targets

Several brokerages recently weighed in on AVTR. Morgan Stanley set a $10.00 price target on shares of Avantor in a research report on Friday, February 13th. Zacks Research raised shares of Avantor from a “strong sell” rating to a “hold” rating in a research report on Thursday, April 30th. Wells Fargo & Company cut their target price on shares of Avantor from $16.00 to $14.00 and set an “overweight” rating for the company in a research report on Friday, February 13th. Barclays cut their target price on shares of Avantor from $8.50 to $7.00 and set an “underweight” rating for the company in a research report on Tuesday, April 14th. Finally, Citigroup cut their target price on shares of Avantor from $11.00 to $9.00 and set a “neutral” rating for the company in a research report on Thursday, April 30th. Two analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, Avantor presently has a consensus rating of “Reduce” and a consensus price target of $10.57.

Avantor Company Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.